Document is current
Any future updates will be listed below
-
Authors
Sheahan, Timothy P. http://orcid.org/0000-0001-9181-2183
Sims, Amy C.
Leist, Sarah R.
Schäfer, Alexandra
Won, John
Brown, Ariane J.
Montgomery, Stephanie A. http://orcid.org/0000-0001-8012-5302
Hogg, Alison
Babusis, Darius http://orcid.org/0000-0001-5599-1671
Clarke, Michael O.
Spahn, Jamie E.
Bauer, Laura
Sellers, Scott
Porter, Danielle
Feng, Joy Y.
Cihlar, Tomas
Jordan, Robert
Denison, Mark R. http://orcid.org/0000-0003-2655-0900
Baric, Ralph S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI132178)
Gilead Sciences
- License Information
-
More Information
Article History
Received: 3 January 2019
Accepted: 7 December 2019
First Online: 10 January 2020
Competing interests
: A.C.S. received a contract from Gilead Sciences to support the in vitro and in vivo efficacy studies reported herein. These authors are employees of Gilead Sciences and hold stock in Gilead Sciences: Alison Hogg, Darius Babusis, Michael O. Clarke, Jamie E. Spahn, Laura Bauer, Scott Sellers, Danielle Porter, Joy Y. Feng, Tomas Cihlar, and Robert Jordan.
